Ballet V - Search Results

1

Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease.

Jürgens M, Mahachie John JM, Cleynen I, Schnitzler F, Fidder H, van Moerkercke W, Ballet V, Noman M, Hoffman I, van Assche G, Rutgeerts PJ, van Steen K, Vermeire S. Jürgens M, et al. Among authors: ballet v. Clin Gastroenterol Hepatol. 2011 May;9(5):421-7.e1. doi: 10.1016/j.cgh.2011.02.008. Epub 2011 Feb 17. Clin Gastroenterol Hepatol. 2011. PMID: 21334460

2

Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience.

Billiet T, Cleynen I, Ballet V, Ferrante M, Van Assche G, Gils A, Vermeire S. Billiet T, et al. Among authors: ballet v. Aliment Pharmacol Ther. 2016 Oct;44(7):673-83. doi: 10.1111/apt.13754. Epub 2016 Aug 9. Aliment Pharmacol Ther. 2016. PMID: 27502581 Free article.

3

Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study.

Breynaert C, Ferrante M, Fidder H, Van Steen K, Noman M, Ballet V, Vermeire S, Rutgeerts P, Van Assche G. Breynaert C, et al. Among authors: ballet v. Am J Gastroenterol. 2011 Apr;106(4):778-85. doi: 10.1038/ajg.2011.61. Epub 2011 Mar 15. Am J Gastroenterol. 2011. PMID: 21407184

4

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.

Schnitzler F, Fidder H, Ferrante M, Ballet V, Noman M, Van Assche G, Spitz B, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Schnitzler F, et al. Among authors: ballet v. Inflamm Bowel Dis. 2011 Sep;17(9):1846-54. doi: 10.1002/ibd.21583. Epub 2011 Jan 6. Inflamm Bowel Dis. 2011. PMID: 21830263

5

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial.

Van Assche G, Vermeire S, Ballet V, Gabriels F, Noman M, D'Haens G, Claessens C, Humblet E, Vande Casteele N, Gils A, Rutgeerts P. Van Assche G, et al. Among authors: ballet v. Gut. 2012 Feb;61(2):229-34. doi: 10.1136/gutjnl-2011-300755. Epub 2011 Sep 23. Gut. 2012. PMID: 21948942 Clinical Trial.

6

Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.

Drobne D, Bossuyt P, Breynaert C, Cattaert T, Vande Casteele N, Compernolle G, Jürgens M, Ferrante M, Ballet V, Wollants WJ, Cleynen I, Van Steen K, Gils A, Rutgeerts P, Vermeire S, Van Assche G. Drobne D, et al. Among authors: ballet v. Clin Gastroenterol Hepatol. 2015 Mar;13(3):514-521.e4. doi: 10.1016/j.cgh.2014.07.027. Epub 2014 Jul 25. Clin Gastroenterol Hepatol. 2015. PMID: 25066841

7

Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.

Vande Casteele N, Ferrante M, Van Assche G, Ballet V, Compernolle G, Van Steen K, Simoens S, Rutgeerts P, Gils A, Vermeire S. Vande Casteele N, et al. Among authors: ballet v. Gastroenterology. 2015 Jun;148(7):1320-9.e3. doi: 10.1053/j.gastro.2015.02.031. Epub 2015 Feb 24. Gastroenterology. 2015. PMID: 25724455 Clinical Trial.

8

Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease.

Billiet T, Cleynen I, Ballet V, Claes K, Princen F, Singh S, Ferrante M, Van Assche G, Gils A, Vermeire S. Billiet T, et al. Among authors: ballet v. Scand J Gastroenterol. 2017 Oct;52(10):1086-1092. doi: 10.1080/00365521.2017.1339825. Epub 2017 Jun 16. Scand J Gastroenterol. 2017. PMID: 28622097

9

Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients.

Detrez I, Thomas D, Van Steen K, Ballet V, Peeters M, Hoylaerts MF, Van Assche G, Vermeire S, Ferrante M, Gils A. Detrez I, et al. Among authors: ballet v. J Clin Gastroenterol. 2020 Oct;54(9):819-825. doi: 10.1097/MCG.0000000000001290. J Clin Gastroenterol. 2020. PMID: 31789759

10

Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease.

Lobatón T, Ferrante M, Rutgeerts P, Ballet V, Van Assche G, Vermeire S. Lobatón T, et al. Among authors: ballet v. Aliment Pharmacol Ther. 2015 Aug;42(4):441-51. doi: 10.1111/apt.13294. Epub 2015 Jun 24. Aliment Pharmacol Ther. 2015. PMID: 26104047 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page